Name: IMCR Income Statement - Immunocore Holdings. Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

IMCR - Immunocore Holdings. PLC

USD | NASDAQ | Healthcare

IMCR Income Statement - Immunocore Holdings. Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23
Revenues
Revenues	106.7	104.5	103.7	98.0	93.9	84.1	80.2	75.4	70.5	70.2	64.9	59.8	54.7
Cost of Revenue	0.4	2.7	0.5	1.0	0.8	0.3	0.4	1.7	0.2	0.2	0.3	0.3	0.2
Gross Profit	106.2	101.8	103.2	96.9	93.1	83.7	79.8	73.7	70.3	70.0	64.6	59.4	54.4
Operating Expenses
Research & Development	61.1	78.8	70.6	69.0	56.5	60.9	52.8	51.1	57.5	45.6	43.2	38.2	36.6
Selling General & Administrative
Operating Income
Operating Income	7.3	(19.7)	(7.2)	(14.9)	(3.6)	(19.5)	(8.5)	(16.0)	(26.5)	(17.1)	(14.1)	(13.8)	(14.7)
Non-Operating
Interest Income	3.4	3.9	4.1	4.3	4.2	5.2	6.0	6.2	8.2	5.4	5.1	4.3	3.1
Interest Expense	3.1
Tax & Net
Income Tax Expense	0.3	14.3	0.5	0.6	1.1	(1.1)	(2.6)	1.5	0.4	(5.9)	(0.2)	0.2	0.3
Net Income From Continuing Ops
Per Share
EPS Basic	0.26	-	0.00	(0.20)	0.10	-	0.17	(0.23)	(0.49)	-	0.02	(0.35)	(0.40)
EPS Diluted	0.25
Supplementary Data
EBITDA	8.2	-	-	-	(2.8)	-	-	-	(25.5)	-	-	-	(13.7)
EBIT	7.3	(19.7)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues
Revenues	412.8	400.0	310.2	249.4	174.4	36.5
Cost of Revenue	4.7	5.1	2.7	1.0	1.1	0.0
Gross Profit	408.1	394.9	307.5	248.4	173.3	36.5
Operating Expenses
Research & Development	279.5	274.9	222.2	163.5	101.9	100.2
Selling General & Administrative	163.1	165.4	155.8	144.5	123.1	110.8
Operating Income
Operating Income	(34.5)	(45.4)	(70.5)	(59.6)	(51.7)	(174.6)
Non-Operating
Interest Income	15.7	16.5	25.6	18.0	3.8	0.1
Interest Expense	12.2	12.2	18.8	5.2	5.4	5.6
Income From Equity Investments
Tax & Net
Income Tax Expense	15.7	16.4	(1.9)	(5.6)	11.7	0.2
Net Income From Continuing Ops	(27.6)	(35.5)	(51.1)	(55.3)	(52.5)	(180.0)
Net Income From Discontinued Ops
Per Share
EPS Basic	(0.54)	(0.71)	(1.02)	(1.13)	(1.15)	(4.24)
EPS Diluted	(0.52)	(0.71)	(1.02)	(1.13)	(1.15)	(4.24)
Shares Basic
Supplementary Data
EBITDA	-	(42.3)	(66.3)	(55.5)	(46.4)	(167.0)
EBIT	(34.5)	(45.4)	(70.5)	(59.6)	(51.7)	(174.6)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)